Literature DB >> 26793340

The future of left ventricular assist devices.

Ahmet Kilic1.   

Abstract

The widespread acceptance of left ventricular assist device (LVAD) implantation in the treatment of heart failure has revolutionized the way end stage heart failure is treated. Advances in LVAD technology combined with a better understanding of patient selection has led to unparalleled survival as well as a reduction in the adverse event profile of these pumps. As our understanding of heart failure continues to grow, there is little doubt that LVADs will continue to play a pivotal role as a therapeutic option for those suffering from heart failure.

Entities:  

Keywords:  Left ventricular assist device (LVAD); mechanical circulatory support (MCS)

Year:  2015        PMID: 26793340      PMCID: PMC4703685          DOI: 10.3978/j.issn.2072-1439.2015.11.01

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  31 in total

Review 1.  Right ventricular failure after left ventricular assist devices.

Authors:  Brent C Lampert; Jeffrey J Teuteberg
Journal:  J Heart Lung Transplant       Date:  2015-07-10       Impact factor: 10.247

2.  Sixth INTERMACS annual report: a 10,000-patient database.

Authors:  James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2014-04-21       Impact factor: 10.247

3.  Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: design and rationale of the ROADMAP clinical trial.

Authors:  Joseph G Rogers; Andrew J Boyle; John B O'Connell; Douglas A Horstmanshof; Donald C Haas; Mark S Slaughter; Soon J Park; David J Farrar; Randall C Starling
Journal:  Am Heart J       Date:  2014-11-11       Impact factor: 4.749

4.  Increasing Frequency of Left Ventricular Assist Device Exchanges in the United States.

Authors:  Fenton H McCarthy; Dale Kobrin; J Eduardo Rame; Peter W Groeneveld; Katherine M McDermott; Pavan Atluri; Michael A Acker; Nimesh D Desai
Journal:  Ann Thorac Surg       Date:  2015-07-21       Impact factor: 4.330

5.  Unexpected abrupt increase in left ventricular assist device thrombosis.

Authors:  Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira
Journal:  N Engl J Med       Date:  2013-11-27       Impact factor: 91.245

6.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

7.  Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality.

Authors:  Jennifer C Matthews; Francis D Pagani; Jonathan W Haft; Todd M Koelling; David C Naftel; Keith D Aaronson
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

8.  Remote monitoring of left ventricular assist device parameters after HeartAssist-5 implantation.

Authors:  Erman Pektok; Zumrut Tuba Demirozu; Nurcan Arat; Omer Yildiz; Emine Oklu; Deniz Eker; Ferah Ece; Cavlan Ciftci; Nuran Yazicioglu; Osman Bayindir; Deniz Suha Kucukaksu
Journal:  Artif Organs       Date:  2013-08-22       Impact factor: 3.094

9.  Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation.

Authors:  Jerry D Estep; Andrea M Cordero-Reyes; Arvind Bhimaraj; Barry Trachtenberg; Nashwa Khalil; Matthias Loebe; Brian Bruckner; Carlos M Orrego; Jean Bismuth; Neal S Kleiman; Guillermo Torre-Amione
Journal:  JACC Heart Fail       Date:  2013-09-11       Impact factor: 12.035

10.  Principles of HeartMate II implantation to avoid pump malposition and migration.

Authors:  Robert M Adamson; Abeel A Mangi; Robert L Kormos; David J Farrar; Walter P Dembitsky
Journal:  J Card Surg       Date:  2014-12-04       Impact factor: 1.620

View more
  6 in total

1.  Diagnosis of infection in patients with left ventricular assist device: PET or SPECT?

Authors:  Damien Legallois; Alain Manrique
Journal:  J Nucl Cardiol       Date:  2018-06-12       Impact factor: 5.952

2.  Left Ventricular Assist Device Infections: A Systematic Review.

Authors:  John C O'Horo; Omar M Abu Saleh; John M Stulak; Mark P Wilhelm; Larry M Baddour; M Rizwan Sohail
Journal:  ASAIO J       Date:  2018 May/Jun       Impact factor: 2.872

Review 3.  Advancements in mechanical circulatory support for patients in acute and chronic heart failure.

Authors:  Thomas A Csepe; Ahmet Kilic
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  Detecting Suspected Pump Thrombosis in Left Ventricular Assist Devices via Acoustic Analysis.

Authors:  Beren Semiz; Sinan Hersek; Maziyar Baran Pouyan; Cynthia Partida; Leticia Blazquez-Arroyo; Van Selby; Georg Wieselthaler; James M Rehg; Liviu Klein; Omer T Inan
Journal:  IEEE J Biomed Health Inform       Date:  2020-01-13       Impact factor: 5.772

5.  Triple bridge of mechanical circulatory support to heart transplantation listing: A case report.

Authors:  Magdy Mohamed El-Sayed Ahmed; Mathew Thomas; Samuel Jacob; Ian A Makey; Kevin P Landolfo; Si M Pham; Erol V Belli
Journal:  SAGE Open Med Case Rep       Date:  2019-03-05

6.  Stroke Risk Following Infection in Patients with Continuous-Flow Left Ventricular Assist Device.

Authors:  Sung-Min Cho; Nader Moazami; Stuart Katz; Adarsh Bhimraj; Nabin K Shrestha; Jennifer A Frontera
Journal:  Neurocrit Care       Date:  2019-08       Impact factor: 3.210

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.